Company Overview
THERIVA BIOLOGICS, INC.
TOVXRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
—M
2025 FY
Net Income
-24M
2025 FY
Shares Outstanding
12M
2025 FY
EPS
-2.08USD
2025 FY
Company Information
SIC Code
2834
CIK Code
894158
Exchange
NYSE
Location
US